MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Oncothyreon Company Profile (NASDAQ:ONTY)

Consensus Ratings for Oncothyreon (NASDAQ:ONTY) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $3.50 (189.26% upside)

Analysts' Ratings History for Oncothyreon (NASDAQ:ONTY)
Show:
DateFirmActionRatingPrice TargetActions
4/17/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2016Cantor FitzgeraldReiterated RatingHold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Raymond JamesLower Price Target$5.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/29/2015Jefferies GroupInitiated CoverageBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2015HC WainwrightReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2014WedbushInitiated CoverageBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/3/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha